Global Partnership with Roche
First written in FY2021-Q3. 2 of 4 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024RestatedAnnual report
「Global partnership between the company and Roche (Note)」
Regarding the global partnership with Roche, the company has reiterated the agreement's provisions covering the sale and servicing of hematology products, non-exclusive collaboration across multiple fields, use of IT platforms and collaboration themes aimed at resolving social issues. - FY2024-Q2AdvancedAnnual report
「Against this backdrop, the company expanded its Global Business Partnership Agreement (the "GBP Agreement") with Roche Diagnostics International Ltd. ("Roche") to address long-term challenges jointly, with the aim of delivering greater value to clinical laboratory customers and helping realize a sustainable society. The updated GBP Agreement includes renewal of the non-exclusive collaboration agreement concerning opportunities requiring a single supplier for biochemistry and immunoassay products and hematology products, as well as the addition of a collaboration agreement to begin considering collaboration themes aimed at resolving environmental issues. Going forward, the companies will pursue medium- to long-term mutual collaboration with Roche, including the sharing of management resources and complementary supply chains, to provide high-value products and services that exceed customer expectations and co-create new value to help resolve social issues.」
The company expanded the scope of its GBP Agreement with Roche to include medium- to long-term collaboration on themes aimed at resolving environmental issues, sharing management resources and complementing supply chains, in addition to renewing non-exclusive collaboration agreements covering multiple testing fields. - FY2021RestatedAnnual report
「Agreement with Roche for the sale and servicing of the company's products in the hematology testing field (term: from 1 January 2021 to 31 August 2026)」
Regarding the global partnership with Roche, the company has reiterated the agreement's provisions covering the sale and servicing of hematology products, non-exclusive collaboration and consideration of collaboration using IT platforms. - FY2021-Q3First statedAnnual report
「Global partnership between the company and Roche (Note)」
The company entered into a global partnership agreement with Roche Diagnostics for the period from January 2021 to December 2030. The agreement includes the sale and servicing by Roche of the company's products in the hematology testing field, non-exclusive collaboration concerning biochemistry, immunoassay and hematology products, and consideration of collaboration to improve customer service and clinical value by leveraging both companies' IT platforms.